District Court Interprets EKRA
FDA Law Blog
JANUARY 6, 2022
In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs Haw., The Eliminating Kickbacks in Recovery Act (“EKRA”). 18 U.S.C. §
52 
Let's personalize your content